We therefore aimed to identify the effects of FGF23 independent of kidney disease by studying a prospective cohort with normal kidney function, but with CV risk factors that included diabetes, hypertension, and hyperlipidemia. The gene discussed is FGF23; the disease is hypertensive disorder.